Redhill Biopharma Ltd
NASDAQ:RDHL
Redhill Biopharma Ltd
Cash Interest Paid
Redhill Biopharma Ltd
Cash Interest Paid Peer Comparison
Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors
Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Redhill Biopharma Ltd
NASDAQ:RDHL
|
Cash Interest Paid
$3.2m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
I
|
InterCure Ltd
TASE:INCR
|
Cash Interest Paid
₪20.9m
|
CAGR 3-Years
508%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Mediwound Ltd
NASDAQ:MDWD
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Cash Interest Paid
₪8.6m
|
CAGR 3-Years
10%
|
CAGR 5-Years
16%
|
CAGR 10-Years
1%
|
See Also
What is Redhill Biopharma Ltd's Cash Interest Paid?
Cash Interest Paid
3.2m
USD
Based on the financial report for Dec 31, 2023, Redhill Biopharma Ltd's Cash Interest Paid amounts to 3.2m USD.
What is Redhill Biopharma Ltd's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 3Y
-21%
Over the last year, the Cash Interest Paid growth was -61%. The average annual Cash Interest Paid growth rates for Redhill Biopharma Ltd have been -21% over the past three years .